跳至主要内容
临床试验/NCT07216716
NCT07216716招募中不适用

Evaluating the Effectiveness of the Health App Recommendation Tool

University of Pittsburgh1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2025年12月5日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
15
试验地点
1
主要终点
World Health Organization Quality of Life (WHOQOL-BREF)

研究概览

简要总结

This study aims to assess the effectiveness of the Health App Recommendation Tool (HART), an evidence-based tool that evaluates app features and matches them to the needs, abilities, and preferences of individuals with Alzheimer's disease and related dementias (ADRD) or their caregivers. This novel tool is not an app in and of itself, but rather an assessment tool used to determine how well suited a given app is for a member of the ADRD or caregiver population.

Specifically, the objective of this research is to assess the acceptability of the current HART design among target end-users in their individual contexts. The overarching goal of this project is to connect those in the ADRD community with available, usable, and effective digital tools to promote the highest possible level of health and wellness in community settings.

To achieve this goal, the study will recruit 15 family caregivers living with their loved ones with ADRD, who will trial HART and provide feedback. Participation will include two data collection sessions (pre-intervention and post-intervention) within a four-week trial period. Participants will be asked to complete the HART, explore the recommended apps, and provide feedback on HART's usability through several brief surveys.

详细描述

Dementia caregiving is a growing challenge predominantly shouldered by young and middle-aged adults, who often face significant physical and mental health needs. Despite the availability of numerous smart health technologies capable of addressing these needs, caregivers frequently encounter difficulties identifying appropriate health applications due to the overwhelming number of options and lack of clear guidance.

Proposed Solution: To bridge this gap, the Health App Recommendation Tool (HART) has been developed as a user-friendly platform designed to connect dementia caregivers with biomedical health apps tailored to their individual requirements.

HART operates by gathering targeted information from users regarding their specific needs, accessibility considerations, available supports, and technology literacy through a brief intake survey. A sophisticated matching algorithm then evaluates these user profiles against a library of health apps that have been objectively reviewed, providing a curated list of the most suitable applications for each caregiver. This personalized approach aims to facilitate the adoption and sustained use of health apps, thereby enhancing caregivers' health and quality of life.

Preliminary evaluations indicate that HART holds promise in setting a new standard in personalized health technology, offering a practical solution for dementia caregivers navigating the extensive and uncharted landscape of biomedical health applications that address their individual and multifaceted needs. By simplifying the process of finding suitable health technologies, HART not only alleviates the burden on caregivers but also empowers them to manage their own health and caregiving responsibilities more effectively. The ongoing refinement and evaluation of HART are crucial to ensuring its effectiveness and widespread adoption, ultimately contributing to improved health outcomes for dementia caregivers and their care recipients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 18 and 65
  • Serving as an active caregiver for a loved one with Alzheimer's disease or a related dementia
  • Have access to smart devices such as smartphones, tablets, or smartwatches

排除标准

  • Individuals with Alzheimer's disease or a related dementia, or with severe cognitive decline, will be excluded
  • Participants who do not provide caregiving on a routine basis (e.g., part-time or secondary caregivers) will be excluded
  • Participants who do not own or have access to any smart device will be excluded

研究组 & 干预措施

HART Use

Experimental

After providing consent, participants will complete baseline surveys via REDCap, followed by a 35-minute virtual onboarding session on Microsoft Teams. During onboarding, participants will learn about the Health App Recommendation Tool (HART) and create a profile. Using an algorithm, HART matches participant needs with health apps, displaying the top three to four recommendations. Study staff will record these apps and provide download guidance. No app data will be shared with the team. Participants may use the apps as they choose over a four-week period. Afterward, follow-up assessments will be sent via REDCap, including WHOQoL, SF-36, PHQ-4, ZBI, Global Fatigue Index, and Davis Usability Surveys. Both baseline and follow-up surveys take about 35 minutes to complete.

干预措施: Health App Recommendation Tool (HART) (Other)

结局指标

主要结局

World Health Organization Quality of Life (WHOQOL-BREF)

时间窗: Baseline and 4 week follow-up

The WHOQOL-BREF, developed by the World Health Organization, is a measure of perceived quality of life. It includes 26 items across Physical Health, Psychological, Social Relationships, and Environment domains, along with two stand-alone global items assessing overall quality of life and health. Each domain score is transformed to a 0-100 scale, with higher scores indicative of a better quality of life.

36-Item Short Form Health Survey (SF-36)

时间窗: Baseline and 4 week follow-up

The SF-36 is a widely used measure of health-related quality of life that captures eight dimensions: Physical Functioning, Role Limitations due to Physical Health, Bodily Pain, General Health, Vitality, Social Functioning, Role Limitations due to Emotional Problems, and Mental Health. All items are scored from 0 to 100, with higher scores indicative of better health status. Scale scores are produced by averaging scores across items in that respective scale.

Patient Health Questionnaire-4 (PHQ-4)

时间窗: Baseline and 4 week follow-up

The PHQ-4 is an brief screening tool designed to assess anxiety and depressive symptoms over the past two weeks. It contains four items, each rated from 0 ("not at all") to 3 ("nearly every day"). Subscale scores for anxiety and depression range from 0-6 each, and the total score ranges from 0-12, with higher scores indicating greater psychological distress. Total scores of 0-2 suggest no distress, 3-5 mild, 6-8 moderate, and 9-12 severe distress.

Zarit Burden Interview (ZBI)

时间窗: Baseline and 4 week follow-up

The Zarit Burden Interview assesses the level of burden experienced by informal caregivers. The 22 items are rated on a 5-point Likert scale from 0 ("never") to 4 ("nearly always"), yielding a total score ranging from 0 to 88. Higher scores indicate greater perceived caregiver burden. Typical interpretive ranges classify scores of 0-21 as little or no burden, 21-40 as mild to moderate burden, 41-60 as moderate to severe burden, and 61-88 as severe burden.

Global Fatigue Index (GFI)

时间窗: Baseline and 4 week follow-up

The Global Fatigue Index is composite measure of fatigue severity and impact. It integrates ratings of fatigue intensity, distress, timing, and interference with daily activities, all on a 1-10 scale, and the final frequency question on a scale of 0-4. Higher total scores indicate greater fatigue.

次要结局

  • Davis Usability Surveys(4 week follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Julie Faieta

Assistant Professor

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验